Vincenzo Petrozza | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Are early continence recovery and oncological outcomes influenced by use of different devices in prostatic apex dissection during laparoscopic radical prostatectomy?	European urology. SupplementsEUROPEAN UROLOGY. SUPPLEMENTS	2015
Can daily intake of aspirin and/or statins influence the behaviour of non-muscle-invasive bladder cancer? a retrospective study on a large cohort of patients undergoing transurethral bladder resection	European urology. SupplementsEUROPEAN UROLOGY. SUPPLEMENTS	2015
Correlation between semiquantitative sonoelastography and immunohistochemestry in the evolution of testicular focal lesions	European urology. SupplementsEUROPEAN UROLOGY. SUPPLEMENTS	2015
Oncogenic microRNAs characterization in clear cell renal cell carcinoma	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2015
Evaluation of the management of Hr-HPV+/PapTest- women. Results at 1-year recall	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY	2015
Primary HPV test screening in cervical cancer: a two-year experience of a single screening center in Latina (Italy).	EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY	2015
Direct correlation between double K-RAS mutation and mucinous carcinoma. A case report	APPLIED IMMUNOHISTOCHEMISTRY AND MOLECULAR MORPHOLOGY	2015
ARE EARLY CONTINENCE RECOVERY AND ONCOLOGICAL OUTCOMES BIASED BY THE USE OF DIFFERENT DEVICES IN PROSTATIC APEX DISSECTION DURING LAPAROSCOPIC RADICAL PROSTATECTOMY?	ABSTRACTS OF THE 25th ANNUAL MEETING OF THE ITALIAN SOCIETY OF URO-ONCOLOGY (SIUrO)ANTICANCER RESEARCH	2015
PURE INTRACORPOREAL LAPAROSCOPIC RADICAL CYSTECTOMY WITH ORTHOTOPIC "U"-SHAPED ILEAL NEOBLADDER	ANTICANCER RESEARCH	2015

Progetti di Ricerca

RNA methylation factors as novel biomarkers in clear cell Renal Cell Carcinoma (ccRCC)
Contribution and clinical relevance of m6A RNA Methylation Regulators in clear cell Renal Cell Carcinoma (ccRCC)
Characterization and clinical relevance of HIF-1alpha/miR-210-3p-associated pathway in Clear Cell Renal Cell Carcinoma
Identification of clinical relevant biomarkers to improve clear cell renal cell carcinoma (ccRCC) management.
Evaluation of miR-210-3p contribution to the establishment and drug responsiveness of clear cell Renal Cell Carcinoma (ccRCC) and its relevance as potential biomarker for the metastatic progression.